Free Trial

Meeder Asset Management Inc. Acquires 3,214 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background
Remove Ads

Meeder Asset Management Inc. lifted its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 14,609.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 3,236 shares of the company's stock after purchasing an additional 3,214 shares during the period. Meeder Asset Management Inc.'s holdings in Molina Healthcare were worth $942,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Cerity Partners LLC lifted its position in Molina Healthcare by 73.2% during the third quarter. Cerity Partners LLC now owns 5,418 shares of the company's stock valued at $1,867,000 after purchasing an additional 2,290 shares during the period. The Manufacturers Life Insurance Company increased its stake in shares of Molina Healthcare by 0.5% in the third quarter. The Manufacturers Life Insurance Company now owns 72,920 shares of the company's stock worth $25,125,000 after purchasing an additional 386 shares in the last quarter. Townsquare Capital LLC bought a new stake in Molina Healthcare during the third quarter valued at about $228,000. Public Sector Pension Investment Board raised its position in shares of Molina Healthcare by 13.5% during the third quarter. Public Sector Pension Investment Board now owns 2,527 shares of the company's stock valued at $871,000 after buying an additional 300 shares during the last quarter. Finally, Verition Fund Management LLC lifted its stake in Molina Healthcare by 626.5% in the 3rd quarter. Verition Fund Management LLC now owns 15,068 shares of the company's stock worth $5,192,000 after purchasing an additional 12,994 shares in the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Molina Healthcare Trading Up 7.5 %

MOH stock traded up $24.79 during midday trading on Thursday, reaching $353.28. 1,226,055 shares of the company's stock traded hands, compared to its average volume of 637,376. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $384.35. The business has a 50-day moving average price of $304.95 and a two-hundred day moving average price of $308.51. The company has a market capitalization of $19.32 billion, a P/E ratio of 17.32, a PEG ratio of 1.06 and a beta of 0.56. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing analysts' consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. Equities research analysts forecast that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the transaction, the director now directly owns 17,375 shares in the company, valued at $5,235,608.75. The trade was a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.10% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Mizuho reduced their target price on shares of Molina Healthcare from $382.00 to $376.00 and set an "outperform" rating on the stock in a report on Monday, March 3rd. UBS Group lowered their target price on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a report on Friday, February 7th. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $350.00 target price (down from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. Truist Financial reduced their price target on shares of Molina Healthcare from $370.00 to $340.00 and set a "buy" rating for the company in a report on Wednesday, February 19th. Finally, Barclays dropped their price objective on shares of Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating on the stock in a research note on Friday, February 7th. Seven equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Molina Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $348.75.

Get Our Latest Research Report on Molina Healthcare

Molina Healthcare Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

See Also

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Best ETFs for Spring 2025: Strong and Steady Investing

Best ETFs for Spring 2025: Strong and Steady Investing

Whether you're after broad market exposure, dividend income, bonds, or even gold, we've got picks that can help you navigate the current investing landscape.

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up
Volatility-Proof Your Portfolio with These 7 ETFs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads